UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37.302

Sortiert nach

Frailty as determined by a comprehensive geriatric assessment‐derived deficit‐accumulation index in older patients with cancer who receive chemotherapy

Cancer, 2016-12, Vol.122 (24), p.3865-3872

2016

Link zum Volltext

Verfügbarkeit prüfen

Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data

Cancer, 2021-03, Vol.127 (5), p.813-814

2021

Link zum Volltext

Verfügbarkeit prüfen

First person profile: Steven Rosenberg, MD, PhD: A trailblazer who helped launch the immunotherapy and gene therapy fields, Dr. Rosenberg continues to work toward curing common metastatic cancers

Cancer, 2020-11, Vol.126 (21), p.4627-4629

Printz, Carrie

2020

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: “A multicountry assessment in Eurasia: Alignment of physician perspectives on palliative care integration in pediatric oncology with World Health Organization guidelines”

Cancer, 2021-12, Vol.127 (23), p.4516-4516

2021

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: “Barriers to the early integration of palliative care in pediatric oncology in 11 Eurasian countries”

Cancer, 2021-12, Vol.127 (23), p.4517-4517

2021

Link zum Volltext

Verfügbarkeit prüfen

First person profile: Joseph Sparano, MD: A respected physician and researcher, Dr. Sparano led the practice-changing TAILORx clinical trial for breast cancer treatment and is working to close disparities in cancer care

Cancer, 2019-12, Vol.125 (23), p.4121-4123

Printz, Carrie

2019

Link zum Volltext

Verfügbarkeit prüfen

Erratum to “Use of a clinical trial screening tool to enhance accrual”

Cancer, 2021-11, Vol.127 (22), p.4313-4313

2021

Link zum Volltext

Verfügbarkeit prüfen

Erratum to “Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration”

Cancer, 2021-09, Vol.127 (17), p.3266-3266

2021

Link zum Volltext

Verfügbarkeit prüfen

A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy

Cancer, 2016-07, Vol.122 (14), p.2158-2167

2016

Link zum Volltext

Verfügbarkeit prüfen

US Food and Drug Administration considers comments on proposed nicotine product regulations: Some criticize the agency for not moving fast enough to stop youth e-cigarette use

Cancer, 2018-10, Vol.124 (20), p.3959-3960

Printz, Carrie

2018

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor

Cancer, 2020-09, Vol.126 (17), p.3893-3894

Printz, Carrie

2020

Link zum Volltext

Verfügbarkeit prüfen

Racism and racial inequities in health care rise to the forefront: Amid the country's national reckoning on race, experts are renewing their focus on systemic racism in the health care system

Cancer, 2020-09, Vol.126 (18), p.4081-4082

Printz, Carrie

2020

Link zum Volltext

Verfügbarkeit prüfen

First person: Hagop Kantarjian, MD: MD Anderson physician reflects on decades of leading research into new leukemia drugs

Cancer, 2018-06, Vol.124 (12), p.2469-2469

Printz, Carrie

2018

Link zum Volltext

Verfügbarkeit prüfen

First person: John Byrd, MD: This Ohio State University researcher has been developing transformative treatments for patients with chronic lymphocytic leukemia, and now is setting his sights on individuals with acute myeloid leukemia

Cancer, 2018-05, Vol.124 (10), p.2069-2069

Printz, Carrie

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling as a novel tool to predict response to interferon‐α2 in MPNs: The proof of concept in early myelofibrosis

Cancer, 2017-07, Vol.123 (14), p.2600-2603

Hasselbalch, Hans Carl

2017

Link zum Volltext

Verfügbarkeit prüfen

The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer

Cancer, 2017-12, Vol.123 (23), p.4720-4727

2017

Link zum Volltext

Verfügbarkeit prüfen

Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia

Cancer, 2018-11, Vol.124 (21), p.4248-4259

2018

Link zum Volltext

Verfügbarkeit prüfen

Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study

Cancer, 2015-09, Vol.121 (17), p.3027-3035

2015

Link zum Volltext

Verfügbarkeit prüfen

Erratum to “MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy”

Cancer, 2021-10, Vol.127 (19), p.3700-3700

2021

Link zum Volltext

Verfügbarkeit prüfen

Erratum to “Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States”

Cancer, 2021-09, Vol.127 (17), p.3267-3267

2021

Link zum Volltext

Verfügbarkeit prüfen

Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma

Cancer, 2013-03, Vol.119 (6), p.1195-1202

2013

Link zum Volltext

Verfügbarkeit prüfen

Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors

Cancer, 2020-04, Vol.126 (8), p.1708-1716

2020

Link zum Volltext

Verfügbarkeit prüfen

Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population‐based study

Cancer, 2017-10, Vol.123 (20), p.4022-4030

2017

Link zum Volltext

Verfügbarkeit prüfen

First person: George Sledge, Jr, MD: Former ASCO president leads breast cancer research and mentors Stanford faculty

Cancer, 2018-09, Vol.124 (17), p.3465-3465

2018

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Cancer, 2008-05, Vol.112 (9), p.1992-2001

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37.302

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBritish Medical Journal

KollektionPublisher website

Zeitschrift / SerieCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37.302)
Mit Volltextzugriff
(37.302)

Publikationsform

Artikel
(37.302)

Sprache

Englisch
(37.302)
Japanisch
(4.550)
Deutsch
(26)
Russisch
(4)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(35.606)
Oncology
(31.954)
Life Sciences & Biomedicine
(31.358)
Science & Technology
(31.358)
Female
(24.470)
Male
(20.642)
Middle Aged
(19.231)
Biological And Medical Sciences
(19.012)
Medical Sciences
(18.965)
Adult
(16.588)
Aged
(15.804)
Tumors
(10.736)
Prognosis
(6.889)
Adolescent
(5.605)
Aged, 80 And Over
(4.661)
Cancer Research
(4.495)
Child
(3.991)
Neoplasm Staging
(3.543)
Retrospective Studies
(3.252)
Follow-Up Studies
(3.212)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

4 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Frailty as determined by a comprehensive geriatric assessment‐derived deficit‐accumulation index in older patients with cancer who receive chemotherapy

Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data

First person profile: Steven Rosenberg, MD, PhD: A trailblazer who helped launch the immunotherapy and gene therapy fields, Dr. Rosenberg continues to work toward curing common metastatic cancers

Erratum to: “A multicountry assessment in Eurasia: Alignment of physician perspectives on palliative care integration in pediatric oncology with World Health Organization guidelines”

Erratum to: “Barriers to the early integration of palliative care in pediatric oncology in 11 Eurasian countries”

First person profile: Joseph Sparano, MD: A respected physician and researcher, Dr. Sparano led the practice-changing TAILORx clinical trial for breast cancer treatment and is working to close disparities in cancer care

Erratum to “Use of a clinical trial screening tool to enhance accrual”

Erratum to “Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration”

A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy

US Food and Drug Administration considers comments on proposed nicotine product regulations: Some criticize the agency for not moving fast enough to stop youth e-cigarette use

Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor

Racism and racial inequities in health care rise to the forefront: Amid the country's national reckoning on race, experts are renewing their focus on systemic racism in the health care system

First person: Hagop Kantarjian, MD: MD Anderson physician reflects on decades of leading research into new leukemia drugs

First person: John Byrd, MD: This Ohio State University researcher has been developing transformative treatments for patients with chronic lymphocytic leukemia, and now is setting his sights on individuals with acute myeloid leukemia

Molecular profiling as a novel tool to predict response to interferon‐α2 in MPNs: The proof of concept in early myelofibrosis

The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer

Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia

Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study

Erratum to “MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy”

Erratum to “Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States”

Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma

Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors

Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population‐based study

First person: George Sledge, Jr, MD: Former ASCO president leads breast cancer research and mentors Stanford faculty

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Aktive Filter

Suchergebnisse filtern